Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BLFS BioLife Solutions	$21.83 -2.2%	$22.86	$18.70 ▼ $29.55	$1.04B	2.01	389,140 shs	786,262 shs
IRTC iRhythm Technologies	$141.37 -0.6%	$118.50	$55.92 ▼ $146.58	$4.51B	1.34	480,444 shs	787,545 shs
PRCT PROCEPT BioRobotics	$58.60 +5.2%	$55.11	$47.04 ▼ $103.81	$3.24B	1.1	823,507 shs	1.08 million shs
SLNO Soleno Therapeutics	$73.24 -3.1%	$71.51	$36.93 ▼ $80.99	$3.69B	-2.67	754,299 shs	1.22 million shs

A Guide To High-Short-Interest Stocks

MarketBeat's analysts have just released their top five short plays for June 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BLFS BioLife Solutions	-2.20%	+0.23%	-9.46%	-9.04%	+1.11%
IRTC iRhythm Technologies	-0.61%	-0.93%	+32.26%	+28.33%	+62.96%
PRCT PROCEPT BioRobotics	+5.19%	+2.13%	+8.56%	-8.92%	-8.58%
SLNO Soleno Therapeutics	-3.15%	-4.75%	-2.16%	+50.02%	+70.76%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
BLFS BioLife Solutions	2.0445 of 5 stars	3.5	1.0	0.0	1.8	2.5	0.6
IRTC iRhythm Technologies	1.671 of 5 stars	2.5	3.0	0.0	4.1	0.0	0.6
PRCT PROCEPT BioRobotics	2.4659 of 5 stars	3.4	1.0	0.0	3.5	2.5	0.6
SLNO Soleno Therapeutics	4.8214 of 5 stars	4.6	3.0	4.6	3.4	3.3	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BLFS BioLife Solutions	3.00	Buy	$31.17	42.77% Upside
IRTC iRhythm Technologies	2.91	Moderate Buy	$133.73	-5.41% Downside
PRCT PROCEPT BioRobotics	2.86	Moderate Buy	$90.00	53.58% Upside
SLNO Soleno Therapeutics	3.11	Buy	$106.78	45.79% Upside

Current Analyst Ratings Breakdown

Latest BLFS, SLNO, IRTC, and PRCT Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
5/22/2025	IRTC iRhythm Technologies	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$130.00 ➝ $167.00
5/13/2025	BLFS BioLife Solutions	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$30.00 ➝ $30.00
5/8/2025	SLNO Soleno Therapeutics	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$81.00 ➝ $97.00
5/8/2025	SLNO Soleno Therapeutics	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$102.00 ➝ $105.00
5/2/2025	IRTC iRhythm Technologies	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$152.00 ➝ $139.00
5/2/2025	IRTC iRhythm Technologies	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$133.00 ➝ $150.00
5/2/2025	IRTC iRhythm Technologies	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Equal Weight ➝ Overweight	$104.00 ➝ $130.00
5/2/2025	IRTC iRhythm Technologies	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$138.00 ➝ $151.00
4/25/2025	PRCT PROCEPT BioRobotics	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$104.00 ➝ $84.00
4/24/2025	SLNO Soleno Therapeutics	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$93.00 ➝ $145.00
4/15/2025	SLNO Soleno Therapeutics	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$100.00 ➝ $100.00

(Data available from 5/31/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BLFS BioLife Solutions	$87.76M	11.82	N/A	N/A	$7.67 per share	2.85
IRTC iRhythm Technologies	$618.59M	7.30	N/A	N/A	$6.85 per share	20.64
PRCT PROCEPT BioRobotics	$249.12M	13.01	N/A	N/A	$5.56 per share	10.54
SLNO Soleno Therapeutics	N/A	N/A	N/A	N/A	$5.16 per share	N/A

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BLFS BioLife Solutions	-$66.43M	-$0.29	N/A	N/A	N/A	-38.98%	-6.61%	-5.54%	8/14/2025 (Estimated)
IRTC iRhythm Technologies	-$123.41M	-$3.14	N/A	N/A	N/A	-19.14%	-118.83%	-11.34%	8/7/2025 (Estimated)
PRCT PROCEPT BioRobotics	-$105.90M	-$1.70	N/A	N/A	N/A	-50.07%	-38.57%	-26.06%	8/7/2025 (Estimated)
SLNO Soleno Therapeutics	-$38.99M	-$4.62	N/A	N/A	N/A	N/A	-61.99%	-55.21%	8/6/2025 (Estimated)

Latest BLFS, SLNO, IRTC, and PRCT Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/8/2025	Q1 2025	BLFS BioLife Solutions	-$0.03	$0.04	+$0.07	-$0.01	$22.22 million	$23.94 million
5/7/2025	Q1 2025	SLNO Soleno Therapeutics	-$1.14	-$0.95	+$0.19	-$0.95	N/A	N/A
5/1/2025	Q1 2025	IRTC iRhythm Technologies	-$0.89	-$0.95	-$0.06	-$0.97	$153.39 million	$158.68 million
4/24/2025	Q1 2025	PRCT PROCEPT BioRobotics	-$0.49	-$0.45	+$0.04	-$0.45	$65.39 million	$69.16 million
3/5/2025	Q4 2024	SLNO Soleno Therapeutics	-$0.86	-$1.27	-$0.41	-$1.27	N/A	N/A
3/3/2025	Q4 2024	BLFS BioLife Solutions	-$0.06	$0.26	+$0.32	$0.26	$21.73 million	$22.71 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
BLFS BioLife Solutions	N/A	N/A	N/A	N/A	N/A
IRTC iRhythm Technologies	N/A	N/A	N/A	N/A	N/A
PRCT PROCEPT BioRobotics	N/A	N/A	N/A	N/A	N/A
SLNO Soleno Therapeutics	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BLFS BioLife Solutions	0.03	2.78	1.78
IRTC iRhythm Technologies	9.00	6.27	6.12
PRCT PROCEPT BioRobotics	0.21	6.02	5.07
SLNO Soleno Therapeutics	N/A	17.26	17.26

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BLFS BioLife Solutions	93.24%
IRTC iRhythm Technologies	N/A
PRCT PROCEPT BioRobotics	89.46%
SLNO Soleno Therapeutics	97.42%

Insider Ownership

Company	Insider Ownership
BLFS BioLife Solutions	2.20%
IRTC iRhythm Technologies	0.68%
PRCT PROCEPT BioRobotics	6.60%
SLNO Soleno Therapeutics	12.30%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BLFS BioLife Solutions	440	47.50 million	45.37 million	Optionable
IRTC iRhythm Technologies	1,790	31.93 million	31.09 million	Optionable
PRCT PROCEPT BioRobotics	430	55.33 million	43.10 million	Optionable
SLNO Soleno Therapeutics	30	50.39 million	37.81 million	Optionable

BLFS, SLNO, IRTC, and PRCT Headlines

Recent News About These Companies

Soleno Therapeutics, Inc. (NASDAQ:SLNO) Shares Acquired by Polar Asset Management Partners Inc.

May 28 at 5:51 AM | marketbeat.com

Q2 EPS Estimate for Soleno Therapeutics Boosted by Analyst

May 27, 2025 | marketbeat.com

HC Wainwright Issues Optimistic Estimate for SLNO Earnings

May 27, 2025 | americanbankingnews.com

Toronto Dominion Bank Makes New $1.17 Million Investment in Soleno Therapeutics, Inc. (NASDAQ:SLNO)

May 26, 2025 | marketbeat.com

Soleno Therapeutics seeking regulatory approval in treatment of PWS

May 24, 2025 | finance.yahoo.com

Soleno Therapeutics, Inc. (SLNO) Secures EMA Validation for PWS Treatment VYKAT XR

May 24, 2025 | finance.yahoo.com

Soleno Therapeutics, Inc. (SLNO) Secures EMA Validation for PWS Treatment VYKAT XR

May 24, 2025 | finance.yahoo.com

Woodline Partners LP Reduces Holdings in Soleno Therapeutics, Inc. (NASDAQ:SLNO)

May 24, 2025 | marketbeat.com

Soleno Therapeutics Announces Submission and EMA Validation of Marketing Authorization Application for Diazoxide Choline Prolonged-Release Tablets for the Treatment of ...

May 23, 2025 | finance.yahoo.com

Soleno Therapeutics, Inc. (NASDAQ:SLNO) Shares Sold by Frazier Life Sciences Management L.P.

May 23, 2025 | marketbeat.com

Soleno Therapeutics, Inc. (SLNO) Secures EMA Validation for PWS Treatment VYKAT XR

May 23, 2025 | insidermonkey.com

Brokerages Set Soleno Therapeutics, Inc. (NASDAQ:SLNO) Target Price at $106.78

May 23, 2025 | americanbankingnews.com

Soleno Therapeutics Announces Submission and EMA Validation of Marketing Authorization Application for Diazoxide Choline Prolonged-Release Tablets for the Treatment of Hyperphagia in Patients with Prader-Willi Syndrome

May 22, 2025 | globenewswire.com

Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A. Acquires Shares of 299,244 Soleno Therapeutics, Inc. (NASDAQ:SLNO)

May 22, 2025 | marketbeat.com

Union Square Park Capital Management LLC Acquires Shares of 50,000 Soleno Therapeutics, Inc. (NASDAQ:SLNO)

May 22, 2025 | marketbeat.com

Rafferty Asset Management LLC Acquires 9,847 Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO)

May 22, 2025 | marketbeat.com

Soleno Therapeutics, Inc. (NASDAQ:SLNO) Receives Average Recommendation of "Buy" from Brokerages

May 22, 2025 | marketbeat.com

Soleno Therapeutics to Participate in Upcoming June Conferences

May 21, 2025 | santelog.com

Soleno Therapeutics Presents Positive Clinical Data for VYKAT™ XR at the 2025 Pediatric Endocrine Society Annual Meeting

May 21, 2025 | nasdaq.com

Vestal Point Capital LP Buys 340,000 Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO)

May 21, 2025 | marketbeat.com

Deutsche Bank AG Purchases 36,971 Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO)

May 21, 2025 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

BLFS, SLNO, IRTC, and PRCT Company Descriptions

BioLife Solutions NASDAQ:BLFS

$21.83 -0.49 (-2.20%)

Closing price 05/30/2025 04:00 PM Eastern

Extended Trading

$21.88 +0.05 (+0.21%)

As of 05/30/2025 06:42 PM Eastern

BioLife Solutions, Inc. develops, manufactures, and markets bioproduction tools and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction tools, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; and the ThawSTAR line that comprises of a family of automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags. The company also provides cryogenic freezer technology for controlled rate freezing and cryogenic storage of biologic materials; ultra-low temperature mechanical freezers; evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage and transport services. It markets and sells its products directly, as well as through third party distributors. The company was incorporated in 1987 and is headquartered in Bothell, Washington.

iRhythm Technologies NASDAQ:IRTC

$141.37 -0.87 (-0.61%)

Closing price 05/30/2025 04:00 PM Eastern

Extended Trading

$140.58 -0.79 (-0.56%)

As of 05/30/2025 04:21 PM Eastern

iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period, including specific arrhythmia events detected by the ZEUS System; the Zio XT System is the previous generation of the Zio Monitor System and is a prescription-only, remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and the Zio AT system, a prescription-only, remote ECG monitoring system that similarly consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days and the ZEUS System, but which also incorporates the Zio AT wireless gateway that provides connectivity between the Zio AT patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.

PROCEPT BioRobotics NASDAQ:PRCT

$58.60 +2.89 (+5.19%)

Closing price 05/30/2025 04:00 PM Eastern

Extended Trading

$57.73 -0.87 (-1.48%)

As of 05/30/2025 07:43 PM Eastern

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.

Soleno Therapeutics NASDAQ:SLNO

$73.24 -2.38 (-3.15%)

Closing price 05/30/2025 04:00 PM Eastern

Extended Trading

$73.31 +0.07 (+0.09%)

As of 05/30/2025 04:44 PM Eastern

Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Extended-Release tablets, a once-daily oral tablet, which is in Phase III clinical trials for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is based in Redwood City, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time